PPA
FLGT icon

Parametric Portfolio Associates’s Fulgent Genetics FLGT Stock Holding History

Parametric Portfolio Associates’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.1M Sell
33,732
-22,565
-40% -$1.49M ﹤0.01% 2402
2021
Q4 		$5.66M Buy
56,297
+13,305
+31% +$1.17M ﹤0.01% 1777
2021
Q3 		$3.87M Buy
42,992
+16,119
+60% +$1.47M ﹤0.01% 2011
2021
Q2 		$2.48M Buy
26,873
+7,043
+36% +$562K ﹤0.01% 2314
2021
Q1 		$1.92M Sell
19,830
-2,985
-13% -$308K ﹤0.01% 2802
2020
Q4 		$1.19M Buy
22,815
+3,435
+18% +$144K ﹤0.01% 2956
2020
Q3 		$776K Buy
19,380
+1,824
+10% +$57.1K ﹤0.01% 3062
2020
Q2 		$281K Sell
17,556
-120,690
-87% -$1.85M ﹤0.01% 3498
2020
Q1 		$1.49M Buy
+138,246
New +$1.93M ﹤0.01% 2562
2019
Q4 		– Sell
-60,000
Closed -$623K – 3972
2019
Q3 		$623K Buy
+60,000
New +$569K ﹤0.01% 3254

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametric Portfolio Associates's FLGT Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Fulgent Genetics (FLGT) stake by 40% in Q1 2022, selling an estimated $1.49M and leaving 33,732 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Parametric Portfolio Associates first reported a position in FLGT in Q3 2019 and has held it in 10 quarters since. The position peaked at $5.66M in Q4 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Parametric Portfolio Associates held 33,732 shares of Fulgent Genetics worth $2.1M as of Q1 2022.
  • Parametric Portfolio Associates sold 22,565 Fulgent Genetics shares in Q1 2022, an estimated $1.49M.
  • Fulgent Genetics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2402 holding.
  • Parametric Portfolio Associates first reported a position in Fulgent Genetics in Q3 2019 and has held it in 10 quarters since.
  • Parametric Portfolio Associates's Fulgent Genetics position peaked at $5.66M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.